Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Recent Patents on Anti-Infective Drug Discovery
|
January 29, 2008
Poxvirus cancer therapy
Philippe-Alexandre Gilbert, Grant McFadden
Biotechnology and Bioengineering
|
June 29, 2007
A simple macroscopic model for the diffusion and adsorption kinetics of r-adenovirus
Philippe-Alexandre Gilbert, Amine Kamen, Alice Bernier, et al.
Journal of Virology
|
August 31, 2007
Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits
Marianne M Stanford, John W Barrett, Philippe-Alexandre Gilbert, et al.
Vaccines
|
September 28, 2024
Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release
Franz Schnetzinger, Didier Clénet, Philippe-Alexandre Gilbert, et al.
Cytotechnology
|
November 13, 2008
Current Status for High Titre Poxvirus Stock Preparation in CEF Under Serum-Free Medium Conditions: Implication for Vaccine Development
Philippe-Alexandre Gilbert, Lacrimioara Comanita, John Barrett, et al.
Virology
|
February 23, 2008
Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity
Jin Su, Christy Willert, Lacrimioara Comanita, et al.
Journal of Neurovirology
|
December 22, 2007
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells
John W Barrett, Lindsay R Alston, Fuan Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 14, 2007
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo
Marianne M Stanford, Mae Shaban, John W Barrett, et al.
Expert Opinion on Drug Delivery
|
January 17, 2023
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities
Tiziana Scarnà, Marion Menozzi-Arnaud, Martin Friede, et al.
Frontiers in Public Health
|
March 21, 2022
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
Mateusz Hasso-Agopsowicz, Natasha Crowcroft, Robin Biellik, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Recent Patents on Anti-Infective Drug Discovery
|
January 29, 2008
Poxvirus cancer therapy
Philippe-Alexandre Gilbert, Grant McFadden
Biotechnology and Bioengineering
|
June 29, 2007
A simple macroscopic model for the diffusion and adsorption kinetics of r-adenovirus
Philippe-Alexandre Gilbert, Amine Kamen, Alice Bernier, et al.
Journal of Virology
|
August 31, 2007
Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits
Marianne M Stanford, John W Barrett, Philippe-Alexandre Gilbert, et al.
Vaccines
|
September 28, 2024
Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release
Franz Schnetzinger, Didier Clénet, Philippe-Alexandre Gilbert, et al.
Cytotechnology
|
November 13, 2008
Current Status for High Titre Poxvirus Stock Preparation in CEF Under Serum-Free Medium Conditions: Implication for Vaccine Development
Philippe-Alexandre Gilbert, Lacrimioara Comanita, John Barrett, et al.
Virology
|
February 23, 2008
Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity
Jin Su, Christy Willert, Lacrimioara Comanita, et al.
Journal of Neurovirology
|
December 22, 2007
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells
John W Barrett, Lindsay R Alston, Fuan Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 14, 2007
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo
Marianne M Stanford, Mae Shaban, John W Barrett, et al.
Expert Opinion on Drug Delivery
|
January 17, 2023
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities
Tiziana Scarnà, Marion Menozzi-Arnaud, Martin Friede, et al.
Frontiers in Public Health
|
March 21, 2022
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
Mateusz Hasso-Agopsowicz, Natasha Crowcroft, Robin Biellik, et al.
Page
of 2